PharmStockPharmacy Stock

LDN
LDN

2.13
A generic medicine indicated for pain and inflammation. Addresses chronic pain signals by modulating the activity of opioid receptors in the body.
Ingredient
Naltrexone
Categories
Oncology Support, Pain & Anti-Inflammatories
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Naltrexone
Reference Brand
Naltrexone
Product Origin
Generic Brand
Product Form
Capsule
Regulatory Classification
Prescription Only Medicine
Primary Category
Pain Relief, Oncology Support
Product Category
Opioid Antagonist
Pharmacological Class
Opioid Receptor Antagonist
Manufacturer Description
Developed to mitigate chronic neuropathic pain and fatigue to support cellular immune safety and target cytokine release.
Mechanism of Action
Blocks opioid receptors transiently, inducing a rebound increase in endogenous endorphin levels and lowering tissue inflammation.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
12–24 hours
Contraindications
Active opioid use, Acute opioid withdrawal, Hepatic failure
Severe Adverse Events
Severe hepatotoxicity — requires immediate medical attention
Common Side Effects
Headache, Nausea, Vivid dreams
Uncommon Side Effects
Insomnia, Mild anxiety, Fatigue
Drug Interactions
Opioid Analgesics
Pregnancy Safety Warnings
TGA Category C: Use with caution. Breastfeeding: Consult a doctor.
Age Restrictions
Approved for adults.
Storage Guidelines
Store below 25°C.
Related Products
Revia, Naltrexone
Information related to LDN is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
how to access Antipsychotic Medication - Latuda Price